Atlas Trials

The Phase II Trial of SHR-1210 Combined With Preoperative Chemotherapy or Apatinib for Locally Advanced ESCC

Clinical trial NCT03917966 · UNKNOWN

Trial details

NCT number
NCT03917966
Sponsor
The First Affiliated Hospital of Zhengzhou University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Locally Advanced Esophageal Squamous Cell Carcinoma
Start date
2020-04-07
Primary completion
2023-10-07
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.